Transgenic and gene knock-out mouse models of sickle cell anemia and the thalassemias

Current Opinion in Hematology

Volumn 4, Issue 2, 1997, Pages 88-93

  Pászty, Chris ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALPHA GLOBIN; BETA GLOBIN; HEMOGLOBIN H;

ALPHA THALASSEMIA; ANIMAL MODEL; BETA THALASSEMIA; FETUS HYDROPS; GENE MUTATION; GLOBIN GENE; MOUSE; MOUSE MUTANT; NONHUMAN; PRIORITY JOURNAL; REVIEW; SICKLE CELL ANEMIA; THALASSEMIA MAJOR; TRANSGENIC MOUSE;

EID: 0030958397     PISSN: 10656251     EISSN: None     Source Type: Journal    
DOI: 10.1097/00062752-199704020-00003     Document Type: Review

References (49)

1. Weatherall DJ, Clegg JB: Thalassemia: a global public health problem. Nature Med 1996, 2:847-849.
2. Smithies O, Gregg RG, Boggs SS, Koralewski MA, Kucherlapati RS: Insertion of DNA sequences into the human chromosomal β-globin locus by homologous recombination. Nature 1985, 317:230-234.
3. Thomas KR, Capecchi MR: Site-directed mutagenesis by gene targeting in mouse embryo-derived stem cells. Cell 1987, 51:503-512.
4. Mansour SL, Thomas KR, Capecchi MR: Disruption of the proto-oncogene int-2 in mouse embryo-derived stem cells: a general strategy for targeting mutations to non-selectable genes. Nature 1988, 336:348-352.
5. Higgs DR, Vickers MA, Wilkie AOM, Pretorius IM, Jarman AP, Weatherall DJ: A review of the molecular genetics of the human α-globin gene cluster. Blood 1989, 73:1081-1104.
6. Liebhaber SA: Alpha thalassemia. Hemoglobin 1989, 13:685-731.
7. Russell LB, Russell WL, Popp RA, Vaughan C, Jacobson KB: Radiation-induced mutations at mouse hemoglobin loci. Proc Natl Acad Sci U S A 1976, 73:2843-2846.
8. Whitney III JB, Russell ES: Linkage of genes for adult α-globin and embryonic α-like globin chains. Proc Natl Acad Sci U S A 1980, 77:1087-1090.
9. Popp RA, Bradshaw BS, Skow LC: Effects of alpha thalassemia on mouse development. Differentiation 1980, 17:205-210.
10. Pászty C, Mohandas N, Stevens ME, Loring JF, Liebhaber SA, Brion CM, Rubin EM: Lethal α-thalassaemia created by gene targeting in mice and its genetic rescue. Nature Genet 1995, 11:33-39. Reports the deletion of both adult α-globin genes and the creation of the first mouse model for severe α-thalassemia. The thalassemic mice are rescued from lethality using a human α-globin transgene. This α-globin deletion is a critical genetic component for the development of murine models of sickle cell disease.
11. Pászty C: Mouse models for the α- and β-thalassemias: the power of transgenic and gene knock-out approaches. Int J Pediatr Hematol/Oncol 1997, 4:75-84.
12. Chang J, Lu RH, Xu SM, Meneses J, Chan K, Pedersen R, Kan YW: Inactivation of mouse α-globin gene by homologous recombination: mouse model of hemoglobin H disease. Blood 1996, 88:1846-1851.
13. Thein SL: β-Thalassaemia. Baillieres Clin Haematol 1993, 6:151-175.
14. Johnson FM, Lewis SE: Electrophoretically detected germinal mutations induced in the mouse by ethylnitrosourea. Proc Natl Acad Sci U S A 1981, 78:3138-3141.
15. Skow LC, Burkhart BA, Johnson FM, Popp RA, Popp DM, Goldberg SZ, Anderson WF, Barnett LB, Lewis SE: A mouse model for β-thalassemia. Cell 1983, 34:1043-1052.
16. Popp RA, Popp DM, Johnson FM, Skow LC, Lewis SE: Hematology of a murine β-thalassemia: a longitudinal study. Ann N Y Acad Sci 1985, 445:432-444.
17. Shehee RW, Oliver P, Smithies O: Lethal thalassemia after insertional disruption of the mouse major adult β-globin gene. Proc Natl Acad Sci U S A 1993, 90:3177-3181.
18. min-globin genes in embryonic stem cells. Proc Natl Acad Sci U S A 1995, 92:9259-9263. Reports the deletion of both adult β-globin genes and the creation of a mouse model of β-thalassemia intermedia. This β-globin deletion is a critical genetic component for the development of murine models of sickle cell disease.
19. o-thalassemia. Proc Natl Acad Sci U S A 1995, 92:11608-11612. Reports the deletion of both adult β-globin genes and the creation of a mouse model of β-thalassemia intermedia. This β-globin deletion is a critical genetic component for the development of murine models of sickle cell disease.
20. Pászty C, Mohandas N, Rubin EM, Kuypers F, Yuan J, Ma L, Schrier SL: A viable murine model of severe β-thalassemia: exploration of the role of programmed cell death (PCD) in ineffective erythropoiesis (IE) [abstract]. Blood 1996, 88:152a. Creation of a mouse model that closely mimics β-thalassemia major/Cooley's anemia. The role of apoptosis in the pathophysiology of β-thalassemia is addressed.
21. Greaves DR, Fraser P, Vidai MA, Hedges MJ, Ropers D, Luzzatto L, Grosveld F: A transgenic mouse model of sickle cell disorder. Nature 1990, 343:183-185.
22. Ryan TM, Townes TM, Reilly MP, Asakura T, Palmiter RD, Brinster RL, Behringer RR: Human sickle hemoglobin in transgenic mice. Science 1990, 247:566-568.
23. s- and α-globins in transgenic mice: hemoglobin composition and hematological consequences. Proc Natl Acad Sci U S A 1992, 89:12150-12154.
24. s- and α-globins in transgenic mice: erythrocyte abnormalities, organ damage, and the effect of hypoxia. Proc Natl Acad Sci U S A 1992, 89:12155-12159.
25. Rubin EM, Witkowska HE, Spangler E, Curtin P, Lubin BH, Mohandas N, Clift SM: Hypoxia-induced in vivo sickling of transgenic mouse red cells. J Clin Invest 1991, 87:639-647.
26. Trudel M, Saadane N, Garel M-C, Bardakdjian-Michau J, Blouquit Y, Guerquin-Kern J-L, Rouyer-Fessard P, Vidaud D, Pachnis A, Roméo P-H, Beuzard Y, Costantini F: Towards a transgenic mouse model of sickle cell disease: hemoglobin SAD. EMBO J 1991, 10:3157-3165.
27. Trudel M, De Paepe ME, Chretien N, Saadane N, Jacmain J, Sorette M, Hoang T, Beuzard Y: Sickle cell disease of transgenic SAD mice. Blood 1994, 84:3189-3197.
28. Fabry ME, Sengupta A, Suzuka SM, Costantini F, Rubin EM, Hofrichter J, Christoph G, Manci E, Culberson D, Factor SM, Nagel RL: A second generation transgenic mouse model expressing both hemoglobin S (HbS) and HbS-Antilles results in increased phenotypic severity. Blood 1995, 86:2419-2428.
29. Pászty C, Brion C, Witkowska E, Mohandas N, Rubin EM: Creation of viable transgenic/gene-knock-out sickle mice that produce exclusively human sickle hemoglobin (HbS) [abstract]. Blood 1996, 88:620a. Reports the creation of mice no longer producing mouse Hb but producing exclusively HbS.
30. Ryan TM, Ciavatta DJ, Townes TM: Mouse model of human sickle cell disease [abstract]. Blood 1996, 88:492a. Reports the creation of mice no longer producing mouse Hb but producing exclusively HbS.
31. Rouyer-Fessard P, Leroy-Viard K, Domenget C, Mrad A, Beuzard Y: Mouse β-thalassemia, a model for the membrane defects of erythro-cytes in the human disease. J Biol Chem 1990, 265:20247-20251.
32. Sorensen S, Rubin E, Polster H, Mohandas N, Schrier S: The role of membrane skeletal-associated α-globin in the pathophysiology of β-thalassemia. Blood 1990, 75:1333-1336.
33. Advani R, Rubin E, Mohandas N, Schrier SL: Oxidative red blood cell membrane injury in the pathophysiology of severe mouse β-thalassemia. Blood 1992, 79:1064-1067.
34. Yuan J, Rubin E, Aljurf M, Ma L, Schrier SL: Defective assembly of membrane proteins in erythroid precursors of β-thalassemic mice. Blood 1994, 84:632-637.
35. Wagemaker G, Visser TP, van Bekkum DW: Cure of murine thalassemia by bone marrow transplantation without eradication of endogenous stem cells. Transplantation 1986, 42:248-251.
36. Bethel CA, Murugesh D, Harrison MR, Mohandas N, Rubin EM: Selective erythroid replacement in murine β-thalassemia using fetal hematopoietic stem cells. Proc Natl Acad Sci U S A 1993, 90:10120-10124.
37. Leroy-Viard K, Rouyer-Fessard P, Beuzard Y: Improvement of mouse β-thalassemia by recombinant human erythropoietin. Blood 1991, 78:1596-1602.
38. Sauvage C, Rouyer-Fessard P, Beuzard Y: Improvement of mouse β-thalassemia by hydroxyurea. Br J Haematol 1993, 84:492-496.
39. Villeval JL, Rouyer-Fessard P, Blumenfeld N, Henri A, Vainchenker W, Beuzard Y: Retrovirus-mediated transfer of the erythropoietin gene in hematopoietic cells improves the erythrocyte phenotype in murine β-thalassemia. Blood 1994, 84:928-933.
40. De Franceschi L, Rouyer-Fessard P, Alper SL, Jouault H, Brugnara C, Beuzard Y: Combination therapy of erythropoietin, hydroxyurea, and clotrimazole in a β-thalassemic mouse: a model for human therapy. Blood 1996, 87:1188-1195.
41. Lutty GA, McLeod DS, Pachnis A, Costantini F, Fabry ME, Nagel RL: Retinal and choroidal neovascularization in a transgenic mouse model of sickle cell disease. Am J Pathol 1994, 145:490-497.
42. De Paepe ME, Trudel M: The transgenic SAD mouse: a model of human sickle cell glomerulopathy. Kidney Int 1994, 46:1337-1345.
43. Bank N, Aynedjian HS, Qiu JH, Osei SY, Ahima RS, Fabry ME, Nagel RL: Renal nitric oxide syntheses in transgenic sickle cell mice. Kidney Int 1996, 50:184-189.
44. - cotransport in the transgenic SAD mouse. Am J Physiol 1995, 269:899-906.
45. Kaul DK, Fabry ME, Costantini F, Rubin EM, Nagel RL: In vivo demonstration of red cell-endothelial interaction, sickling and altered microvascular response to oxygen in the sickle transgenic mouse. J Clin Invest 1995, 96:2845-2853. First in vivo observation (microvideography) of intravascular sickling, erythrocyte-endothelium interaction, and altered microvascular responses to oxygen. This type of approach will be indispensable for studying these phenomena and gaining insight into their roles in vaso-occlusion.
46. Fabry ME, Kennan RP, Pászty C, Costantini F, Rubin EM, Gore JC, Nagel RL: Magnetic resonance evidence of hypoxia in a homozygous alpha-knockout of a transgenic mouse model for sickle cell disease. J Clin Invest 1996, 98:2450-2455.
47. + transport and reverses erythrocyte dehydration in transgenic SAD mice: a model for therapy of sickle cell disease. J Clin Invest 1994, 93:1670-1676.
48. + channel by clotrimazole. Ann N Y Acad Sci 1995, 763:262-271.
49. De Franceschi L, Beuzard Y, Jouault H, Brugnara C: Modulation of erythrocyte potassium chloride cotransport, potassium content and density by dietary magnesium intake in transgenic SAD mouse. Blood 1996, 88:2738-2744.